Xeloda (Page 10 of 10)
PRINCIPAL DISPLAY PANEL — 150 mg Tablet Bottle Carton
NDC 0004-1100-20
Xeloda®
(capecitabine)
Tablets
150 mg
Each tablet contains 150 mgcapecitabine.
Warning: Hazardous Drug
Rx only
60 tablets
Genentech
10250281
PRINCIPAL DISPLAY PANEL — 500 mg Tablet Bottle Carton
NDC 0004-1101-50
Xeloda®
(capecitabine)
Tablets
500 mg
Each tablet contains 500 mgcapecitabine.
Warning: Hazardous Drug
Rx only
120 tablets
Genentech
10250280
XELODA capecitabine tablet, film coated | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
XELODA capecitabine tablet, film coated | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
Labeler — Genentech, Inc. (080129000) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Excella GmbH & Co. KG | 329809800 | ANALYSIS (0004-1100), ANALYSIS (0004-1101), MANUFACTURE (0004-1100), MANUFACTURE (0004-1101), PACK (0004-1100), PACK (0004-1101), LABEL (0004-1100), LABEL (0004-1101) |
Establishment | |||
Name | Address | ID/FEI | Operations |
F. Hoffmann-La Roche Ltd | 485244961 | ANALYSIS (0004-1100), ANALYSIS (0004-1101) |
Establishment | |||
Name | Address | ID/FEI | Operations |
F. Hoffmann-La Roche AG | 482242971 | ANALYSIS (0004-1100), ANALYSIS (0004-1101) |
Establishment | |||
Name | Address | ID/FEI | Operations |
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. | 431189117 | ANALYSIS (0004-1100), ANALYSIS (0004-1101), API MANUFACTURE (0004-1100), API MANUFACTURE (0004-1101) |
Revised: 11/2023 Genentech, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.